FC
TAK icon

FORA Capital’s Takeda Pharmaceutical TAK Stock Holding History

FORA Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,583
Closed -$239K – 673
2022
Q1 		$239K Buy
+16,583
New +$243K 0.04% 443
2021
Q2 		– Sell
-1,021
Closed -$19K – 1140
2021
Q1 		$19K Sell
1,021
-42,067
-98% -$757K 0.01% 693
2020
Q4 		$784K Buy
43,088
+36,955
+603% +$648K 0.12% 192
2020
Q3 		$109K Buy
+6,133
New +$112K 0.07% 289
2020
Q1 		– Sell
-24,978
Closed -$493K – 1331
2019
Q4 		$493K Buy
+24,978
New +$478K 0.05% 399

Other funds holding TAK

MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return